Abstract:Cells of the Caco-2 line have the basic properties of enterocytes of the small intestine, and therefore can be used to study the absorption of medicinal substances. Aim. To characterize the properties of the Caco-2 cell line from the Institute of Cytology of the Russian Academy of Sciences and to evaluate with its help the mechanism of absorption of the original domestic drug - ethylmethylhydroxypyridine succinate (EMGPS). Materials and methods. The study was performed on Caco2 cells that were cultured for 21 days, since at this time their spontaneous differentiation into polarized cells similar to enterocytes of the small intestine occurs. The density of the cell monolayer was estimated by the value of transepithelial resistance. The number of major efflux proteins of glycoprotein-P transporters (Pgp) and breast cancer resistance protein (BCRP) in Caco-2 cells was analyzed using enzyme immunoassay. In specialized transwell systems, the transport of the Pgp substrate fexofenadine (40, 150 and 300 microns), the BCRP substrate methotrexate (5, 10, 50 microns) and EMGPS (10, 100 and 250 microns) through the cell monolayer was studied. The results of the study. By day 21 of cultivation, cells of the Caco2 line formed a merging monolayer with pronounced dense contacts. The amount of Pgp and BCRP was 110.8±14.1 ng/mg and 4.39±0.12 ng/mg, respectively, which correlates with the amount of these proteins in the human small intestine. Transport of fexofenadine (40, 150 and 300 microns) and methotrexate (5 microns) from the basolateral chamber to the apical chamber (corresponding to transport from enterocytes to the intestinal lumen) prevailed over transport in the opposite direction, which is associated with the work of Pgp and BCRP. The transport of EMGPS significantly exceeded the transport of fexofenadine and methotrexate and was symmetrical with respect to the cellular monolayer. Conclusion. Thus, the cells of the Caco-2 line, commercially available in the Russian Federation, have the basic properties of enterocytes of the small intestine, and can be used to study the absorption of medicinal substances in vitro. EMGPS quickly passes through the cellular monolayer, and the mechanism of its absorption is passive diffusion, without the participation of specific transporters.

Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa

Absorption Barriers in the Rat Intestinal Mucosa: 2. Application of Physiologically Based Mathematical Models to Quantify Mechanisms of Drug Permeation and Metabolism

Novel In Vitro Models for Cell Differentiation and Drug Transport Studies of the Human Intestine

Establishment of Caco-2 Cell Monolayer Model and Standard Operation Procedure for Assessing Intestinal Absorption of Chemical Components of Traditional Chinese Medicine

Vitamin D-regulated calcium transport in Caco-2 cells: unique in vitro model

Short Caco-2 model for evaluation of drug permeability: A sodium valerate-assisted approach

Cells of the Caco-2 line as a model for studying the absorption of medicinal substances

Establishment and Validation of Caco-2 Cell Lines for Lntestinal Epithelial Permeability

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux

Estimation of the Relative Contribution of the Transcellular and Paracellular Pathway to the Transport of Passively Absorbed Drugs in the Caco-2 Cell Culture Model

Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers

The in vitro intestinal cell model: different co-cultured cells create different applications

Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis

Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations

Caco-2 Monolayer as a Model of the Intestinal Barrier: Permeability of Magnesium Salts

Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs

Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs

Permeability for Intestinal Absorption: Caco-2 Assay and Related Issues

Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices

Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers